Back
Beam Therapeutics Stock Predictions
Sponsored
BEAM
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
64
BEAM
Beam Therapeutics
Last Price:
27.02
Seasonality Move:
54.38%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Beam Therapeutics Stock Forecast
- Over the next 52 weeks, Beam Therapeutics has on average historically risen by 14.7% based on the past 4 years of stock performance.
- Beam Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
-
Is Beam Therapeutics Stock Undervalued?
The current Beam Therapeutics [BEAM] share price is $27.06. The Score for BEAM is 64, which is 28% above its historic median score of 50, and infers lower risk than normal. - BEAM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Beam Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Beam Therapeutics has on average historically risen by 14.7% based on the past 4 years of stock performance.
Beam Therapeutics Stock Rating
Buy
64
Beam Therapeutics (BEAM)
is a Buy
Is Beam Therapeutics overpriced?
- Beam Therapeutics has risen higher in 1 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 25%
Beam Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com
52-Week Data
52-Week High:
49.50
52-Week Low:
18.85
Prediction Charts
Market Cap:
2.24B
Price in USD:
27.06
Volume:
1.27M
Beta:
1.79
Technical Analysis
SMA50:
24.28
SMA100:
25.10
SMA200:
26.78
52-Wk Change:
18.17%
Stock Predictions
-
Is Beam Therapeutics stock public?
Yes, Beam Therapeutics is a publicly traded company. -
What is the Beam Therapeutics stock quote today?
The Beam Therapeutics stock price is 27.06 USD today. -
How to buy Beam Therapeutics stock online?
You can buy Beam Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-22 | 23.00 | 22.74 | 23.09 | 22.44 |
Oct-23 | 22.63 | 21.82 | 22.76 | 21.76 |
Oct-24 | 22.04 | 22.09 | 22.14 | 21.14 |
Oct-25 | 22.18 | 21.55 | 22.32 | 21.50 |
Oct-28 | 21.90 | 22.35 | 22.74 | 21.68 |
Oct-29 | 22.35 | 22.15 | 22.35 | 21.85 |
Oct-30 | 21.93 | 22.50 | 22.70 | 21.79 |
Oct-31 | 22.61 | 21.92 | 22.61 | 21.86 |
Nov-1 | 22.30 | 22.93 | 23.11 | 22.05 |
Nov-4 | 22.75 | 24.36 | 24.95 | 22.52 |
Nov-5 | 21.62 | 23.93 | 24.79 | 21.46 |
Nov-6 | 26.00 | 26.62 | 27.30 | 25.24 |
Nov-7 | 26.56 | 26.09 | 27.17 | 25.60 |
Nov-8 | 25.88 | 27.06 | 27.38 | 25.68 |
Beam Therapeutics Earnings
Beam Therapeutics Earnings Report: Per Share Beam Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Beam Therapeutics Forecast Revenue Growth
Beam Therapeutics Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.58 per share, and a decrease next year of $0.04 per share.
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.